The origin of intra-ophthalmic artery chemotherapy (SSIOAC) dates back to the 1950s. Cases of advanced intraocular retinoblastoma with (1) large multiple lesions still having enough normal retina so visual preservation was possible, (2) vitreous seeds, or (3) tumors refractory to other treatments presented a challenge for Reese and other early pioneers in the treatment of retinoblastoma, as they unfortunately still do today.
|Original language||English (US)|
|Title of host publication||Clinical Ophthalmic Oncology: Retinoblastoma, Second Edition|
|Publisher||Springer Berlin Heidelberg|
|Number of pages||8|
|ISBN (Print)||9783662434512, 9783662434505|
|State||Published - Jan 1 2015|
ASJC Scopus subject areas